Tilots Pharma AG (manufacturer responsible for batch release)
UkraineAll drugs from this manufacturer
-
The drug is indicated for the treatment of mild to moderate ulcerative colitis, as well as for maintenance therapy during remission.
Dosage form: tablets, modified release
Active substance Dosage mesalazine 1600 mg ATC: A07EC02
-
The drug is used by adults for the treatment of mild to moderate proctitis and proctosigmoiditis, as well as as adjunctive therapy for severe forms of ulcerative colitis affecting the rectum or rectosigmoid region.
Dosage form: suppositories, rectal
Active substance Dosage mesalazine 500 mg ATC: A07EC02